Developing an HPV vaccine to prevent cervical cancer and genital warts.

PubWeight™: 1.21‹?› | Rank: Top 10%

🔗 View Article (PMID 17289220)

Published in Vaccine on January 18, 2007

Authors

Janine T Bryan1

Author Affiliations

1: Vaccine and Biologics Research, Merck Research Laboratories, Merck & Co., Inc., West Point, PA, United States. janine_bryan@merck.com

Articles citing this

Educational interventions to increase HPV vaccination acceptance: a systematic review. Vaccine (2014) 2.30

Anaphylaxis following quadrivalent human papillomavirus vaccination. CMAJ (2008) 1.58

Disassembly and reassembly of human papillomavirus virus-like particles produces more virion-like antibody reactivity. Virol J (2012) 1.04

Perception of barriers to immunization among parents of Hmong origin in California. Am J Public Health (2010) 1.00

In vivo longitudinal imaging of experimental human papillomavirus infection in mice with a multicolor fluorescence mini-endoscopy system. Cancer Prev Res (Phila) (2011) 0.93

Hepatitis B virus and Homo sapiens proteome-wide analysis: A profusion of viral peptide overlaps in neuron-specific human proteins. Biologics (2010) 0.92

Preventive and Therapeutic Vaccines against Human Papillomaviruses Associated Cervical Cancers. Iran J Basic Med Sci (2012) 0.89

The future of vaccines for cervical cancer. Gynecol Oncol (2008) 0.87

Identification of B-cell epitopes on virus-like particles of cutaneous alpha-human papillomaviruses. J Virol (2009) 0.87

From Human Papillomavirus (HPV) Detection to Cervical Cancer Prevention in Clinical Practice. Cancers (Basel) (2014) 0.86

Significance of SHP-1 and SHP-2 expression in human papillomavirus infected Condyloma acuminatum and cervical cancer. Pathol Oncol Res (2008) 0.85

Mechanistic insight into the TH1-biased immune response to recombinant subunit vaccines delivered by probiotic bacteria-derived outer membrane vesicles. PLoS One (2014) 0.84

Polyfunctional CD4+ T cell responses to a set of pathogenic arenaviruses provide broad population coverage. Immunome Res (2010) 0.83

Coverage of related pathogenic species by multivalent and cross-protective vaccine design: arenaviruses as a model system. Microbiol Mol Biol Rev (2010) 0.83

Vaccination with the recombinant major outer membrane protein elicits antibodies to the constant domains and induces cross-serovar protection against intranasal challenge with Chlamydia trachomatis. Infect Immun (2013) 0.82

Human Papillomavirus Infection and Vaccination: Awareness and Knowledge of HPV and Acceptability of HPV Vaccine among Mothers of Teenage Daughters in Weihai, Shandong, China. PLoS One (2016) 0.82

Molecular epidemiology of sexually transmitted human papillomavirus in a self referred group of women in Ireland. Virol J (2009) 0.81

Immunogenicity of individual vaccine components in a bivalent nicotine vaccine differ according to vaccine formulation and administration conditions. PLoS One (2013) 0.80

Enhancement of the protective efficacy of a Chlamydia trachomatis recombinant vaccine by combining systemic and mucosal routes for immunization. Vaccine (2010) 0.80

No human protein is exempt from bacterial motifs, not even one. Self Nonself (2010) 0.79

A Cluster-Randomized Trial to Evaluate a Mother-Daughter Dyadic Educational Intervention for Increasing HPV Vaccination Coverage in American Indian Girls. J Community Health (2016) 0.78

Cloning and Expression of Recombinant Tick-Borne Encephalitis Virus-like Particles in Pichia pastoris. Osong Public Health Res Perspect (2014) 0.75

Silencing sexually transmitted infections: topical siRNA-based interventions for the prevention of HIV and HSV. Infect Dis Obstet Gynecol (2014) 0.75

Perceived behavioral control, intention to get vaccinated, and usage of online information about the human papillomavirus vaccine. Health Psychol Behav Med (2014) 0.75

Label-free quantitative mass spectrometry for analysis of protein antigens in a meningococcal group B outer membrane vesicle vaccine. Hum Vaccin Immunother (2015) 0.75